427 related articles for article (PubMed ID: 23824372)
1. Antianaerobic antimicrobials: spectrum and susceptibility testing.
Brook I; Wexler HM; Goldstein EJ
Clin Microbiol Rev; 2013 Jul; 26(3):526-46. PubMed ID: 23824372
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
Byun JH; Kim M; Lee Y; Lee K; Chong Y
Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
Wexler HM; Molitoris E; Molitoris D; Finegold SM
Antimicrob Agents Chemother; 1996 Sep; 40(9):2232-5. PubMed ID: 8878617
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility testing of anaerobic bacteria.
Rosenblatt JE
Rev Infect Dis; 1984; 6 Suppl 1():S242-8. PubMed ID: 6372033
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility profiles of anaerobic pathogens in The Netherlands.
Veloo AC; van Winkelhoff AJ
Anaerobe; 2015 Feb; 31():19-24. PubMed ID: 25192966
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe.
King A; Downes J; Nord CE; Phillips I;
Clin Microbiol Infect; 1999 Jul; 5(7):404-416. PubMed ID: 11853565
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
Shore KP; Pottumarthy S; Morris AJ
N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
[TBL] [Abstract][Full Text] [Related]
10. Gram negative anaerobe susceptibility testing in clinical isolates using Sensititre and Etest methods.
Hughes C; Ashhurst-Smith C; Ferguson JK
Pathology; 2018 Jun; 50(4):437-441. PubMed ID: 29678480
[TBL] [Abstract][Full Text] [Related]
11. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
Doğan M; Baysal B
Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria.
Ackermann G; Schaumann R; Pless B; Claros MC; Rodloff AC
J Antimicrob Chemother; 2000 Jul; 46(1):115-9. PubMed ID: 10882699
[TBL] [Abstract][Full Text] [Related]
13. High rate of non-susceptibility to metronidazole and clindamycin in anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan.
Sheikh SO; Jabeen K; Qaiser S; Ahsan ST; Khan E; Zafar A
Anaerobe; 2015 Jun; 33():132-6. PubMed ID: 25800668
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitis.
Croco JL; Erwin ME; Jennings JM; Putnam LR; Jones RN
Diagn Microbiol Infect Dis; 1994 Dec; 20(4):213-9. PubMed ID: 7705035
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial Susceptibility of Pathogenic Gram-positive Anaerobic Cocci: Data of a University Hospital in Turkey].
Akgül Ö; Söyletir G; Ülger Toprak N
Mikrobiyol Bul; 2020 Jul; 54(3):404-417. PubMed ID: 32755517
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.
Ackermann G; Schaumann R; Pless B; Claros MC; Goldstein EJ; Rodloff AC
Eur J Clin Microbiol Infect Dis; 2000 Mar; 19(3):228-32. PubMed ID: 10795599
[TBL] [Abstract][Full Text] [Related]
17. A multicenter study of the in vitro antianaerobic activity of cefotetan compared with other antimicrobial agents.
Zabransky RJ; Bobey DG; Sheikh W
Am J Surg; 1988 May; 155(5A):47-51. PubMed ID: 3163901
[TBL] [Abstract][Full Text] [Related]
18. Identification and antimicrobial susceptibility of obligate anaerobic bacteria from clinical samples of animal origin.
Mayorga M; Rodríguez-Cavallini E; López-Ureña D; Barquero-Calvo E; Quesada-Gómez C
Anaerobe; 2015 Dec; 36():19-24. PubMed ID: 26385434
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of faropenem against 579 strains of anaerobic bacteria.
Wexler HM; Molitoris D; St John S; Vu A; Read EK; Finegold SM
Antimicrob Agents Chemother; 2002 Nov; 46(11):3669-75. PubMed ID: 12384389
[TBL] [Abstract][Full Text] [Related]
20. Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents.
Jang SS; Breher JE; Dabaco LA; Hirsh DC
J Am Vet Med Assoc; 1997 Jun; 210(11):1610-4. PubMed ID: 9170087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
